Water-Soluble Arabinoxylan Extraction for Intestinal Barrier Modulation
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for extracting long-chain water-soluble arabinoxylans from wheat are inefficient due to low yields and high costs, and it is assumed that only short-chain arabinoxylans have prebiotic effects, limiting their use in improving intestinal barrier and immune functions.
Innovation Solution
A method to produce a water-extractable arabinoxylan preparation with an average degree of polymerization of at least 60, containing 55% - 85% arabinoxylans, and a novel refining process using cake filtration to achieve high molecular weight and solubility, avoiding enzyme hydrolysis and reducing protein content, thereby enhancing prebiotic and physiological effects.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Quantity of substance
If conventional extraction methods are used to obtain long-chain water-soluble arabinoxylans from wheat, then the extraction process can be completed, but the yield is low and the cost is high
Solution Approach 1:
The patent changes the extraction parameters by using alkali treatment (NaOH at specific concentrations and pH levels) combined with controlled hydrolysis conditions (enzyme type, temperature, time) to optimize the solubility and molecular weight distribution of arabinoxylans. This parameter optimization increases yield while controlling costs through efficient resource utilization.
Solution Approach 2:
The patent applies preliminary alkali treatment to modify the structure of arabinoxylans before extraction, making them more soluble and easier to isolate. This preliminary modification simplifies subsequent extraction steps and increases the overall yield of long-chain water-soluble arabinoxylans.
2Quantity of substance
If enzyme hydrolysis is used to produce arabinoxylans, then the arabinoxylan content increases, but the molecular weight decreases and long-chain structures are lost
Solution Approach 1:
The patent applies partial hydrolysis using specific enzymes (xylanase, beta-glucanase) under controlled conditions (temperature, time, enzyme concentration) to achieve the desired arabinoxylan content without complete degradation. This partial action maintains long-chain structures while increasing soluble arabinoxylan content.
Solution Approach 2:
The patent optimizes hydrolysis parameters including enzyme selection, temperature (30-60°C), pH levels, and treatment time to balance arabinoxylan content increase with preservation of long-chain molecular weight. These parameter controls prevent excessive hydrolysis that would degrade chain length.
3Manufacturing precision
If protein content is reduced in arabinoxylan preparations, then the purity and prebiotic effects are improved, but the extraction and refining process becomes more complex
Solution Approach 1:
The patent extracts and removes proteins from the arabinoxylan preparation using selective precipitation, ultrafiltration, or chromatography methods. This separation process achieves high purity (reducing protein content below specified thresholds) while the methods are integrated into the existing extraction workflow to minimize added complexity.
Solution Approach 2:
The patent adjusts extraction and refining parameters such as pH levels, temperature, ionic strength, and filtration conditions to selectively remove proteins while preserving arabinoxylan structures. These parameter optimizations achieve high purity with controlled process complexity.
4Reliability
If short-chain arabinoxylans are used, then prebiotic effects are established, but the barrier function and immune modulation effects are limited
Solution Approach 1:
The patent changes the molecular weight parameter of arabinoxylans by controlling hydrolysis degree and extraction conditions to produce long-chain structures (high molecular weight fraction). These long-chain arabinoxylans maintain prebiotic effects while providing enhanced barrier function and immune modulation capabilities through their extended molecular structure.
Solution Approach 2:
The patent creates a composite preparation containing both long-chain arabinoxylans and beneficial bacteria (probiotics), synergistically combining the prebiotic effects of arabinoxylans with the direct benefits of probiotic bacteria. This composite approach enhances barrier function and immune modulation while maintaining prebiotic activity.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The method achieves acceptable yields of long-chain soluble arabinoxylans with potent prebiotic and systemic effects, improving intestinal barrier function, metabolic homeostasis, and immune system functioning, while being cost-effective and environmentally friendly.
Implementation Method 1
it is assumed that only short-chain arabinoxylans have prebiotic effects, limiting their use in improving intestinal barrier and immune functions
Implementation Method 2
other bacteria can use them as a means to adhere to the surface. Adherence leads to the formation of an adhesive microbial layer
Implementation Method 3
a novel refining process using cake filtration to achieve high molecular weight and solubility, avoiding enzyme hydrolysis and reducing protein content
Implementation Method 4
modulates the barrier function of the intestinal surface, primarily by modulating the mucosa-associated microbial community
Data Source
Figure 1a~1b
Figure 2~3
Figure 4
AI summary
The present invention is directed to a particular arabinoxylan ("AX") preparation and the finding that this preparation has a beneficial effect on the organization of the intestinal microbial community in the lumen and in particular at the site of the gut mucosa, where it modulates the barrier function of the intestinal surface, primarily by modulating the mucosa-associated microbial community towards a relative increase of health beneficial bacteria, such as bifidobacteria and lactobacilli. It is accordingly a first aspect of the present invention to provide said arabinoxylan preparation characterized in comprising isolated water-soluble arabinoxylans and the use thereof to improve functioning (e.g. barrier function) of the intestinal epithelium. Thus, in a further aspect the present invention provides compositions, both pharmaceutical and nutritional compositions, comprising said arabinoxylan preparations; in particular pharmaceuticals, medical foods, food supplements or food compositions, such as infant formula products, dairy products, bakery products or pastry products. The compositions optionally comprise probiotics such as Bifidobacterium or Lactobacillus.